Press Releases Hemostemix Inc.

Equities

HEM

CA4236943060

Market Closed - Toronto S.E. Other stock markets 02:59:23 2024-05-17 pm EDT			5-day change	1st Jan Change
0.04 ^CAD	0.00%		0.00%	-42.86%

Apr. 30	Hemostemix Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 06	Hemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental Sciences	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hemostemix Announces Engagement of Oak Hill Asset Management Inc.	Mar. 07	NE
Hemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental Sciences	Feb. 06	NE
Hemostemix Clarifies its October 3, 2023 News Release	Dec. 29	NE
Hemostemix's 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart Disease	23-10-30	NE
Hemostemix Announces Amendment of its $2.5 Million 5 Year Convertible Debenture Issued on June 11, 2021, Resulting in an Expected Interest Saving of Approximately $570,000	23-10-23	NE
Hemostemix Closed $320,125 Private Placement	23-10-03	NE
Hemostemix Announces Private Placement	23-09-27	NE
Hemostemix Announces the Incorporation of Hemostemix Quebec Inc. and $6 Million in Grant Applications	23-08-30	AQ
Hemostemix Announces Arbitration Award of CAD $315,684 Plus Private Placement	23-08-15	AQ
The Benefits of ACP-01 Stem Cell Therapy: Can it Save Limbs and thereby Lives	23-07-06	PU
Hemostemix : Benefits of Stem Cell Therapy and How it Can Save Lives	23-07-05	PU
Hemostemix : 2021/2022 Consolidated Financial Statements	23-05-08	PU
Hemostemix : Notice of Annual and Special Meeting of Shareholders	23-05-08	PU
IIROC Trading Resumption - HEM	23-05-02	AQ
IIROC Trading Halt - HEM	23-05-02	AQ
Hemostemix Second Round Interviews with Executive Vice President Business Development Candidates	23-04-04	AQ
Hemostemix Engages Montreal's RobboDesign to SEO its Website to Engage with 236 Million Peripheral Arterial Disease and Critical Limb Ischemia Patients Globally	23-03-30	AQ
HEMOSTEMIX CLOSES $762,400 OF THE UNIT PRIVATE PLACEMENT	23-03-22	AQ
Hemostemix Unit Offering Repriced	23-03-09	AQ
Hemostemix : Offers up to 500 6% Convertible Debentures,Convertible into an ACP-01 Therapeutic Production Slot that is Subject to Compassionate Exemption from Regulatory Approval	23-03-07	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Hemostemix Inc.

Equities

HEM

CA4236943060

Press Releases

Filters